TDX KENAMYCIN— 510(k) K822808

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K822808 for TDX KENAMYCIN, Substantially Equivalent on 1982-10-08. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code KJI
Device class: Class 2
Regulation: 21 CFR 862.3520
Advisory panel: Clinical Toxicology
Date received: 1982-09-17
Decision date: 1982-10-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KJI

K832769 — AMES TDA KANAMYCIN TEST-CONTROL SERUM1983-09-29
K823370 — ADVANCE TM EMIT(R) & TM AMIKACIN ASSAY1982-12-03
K823062 — KENAMYCIN FLUORESCENT IMMUNOASSAY FIA1982-11-10
K782125 — RIA KIT, KANAMYCIN1979-01-10
K772038 — KANAMYCIN RIA1978-01-12

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.